Samsara BioCapital, a venture fund based in Palo Alto, California, was founded in 2016. The fund, led by Partner Cory Freedland, focuses on investments in BioTech, Medical Device, Pharmaceuticals, Healthcare, and Life Science sectors. Samsara BioCapital has made 91 investments in companies like Mineralys Therapeutics, Alamar Biosciences, and A2 Biotherapeutics, with 33 successful exits. They provide investment advisory services for startups at various stages from Pre-Seed to Series D. For more information, visit their website at www.samsaracap.com.